LINEZOLID REDUCES TIME TO RESOLUTION OF VANCOMYCIN-RELATED NEPHROTOXICITY IN NOSOCOMIAL PNEUMONIA

被引：0
|
作者：
Andrews, Lauren [1 ,2 ]
Gregory, Eric [2 ]
Blevins, Adam [2 ]
Archer, Sydney [2 ]
Britt, Nicholas [2 ]
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Kansas Hlth Syst, Kansas City, KS USA
来源：
CRITICAL CARE MEDICINE | 2020年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
591
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
    Mathias W Pletz
    Olaf Burkhardt
    Tobias Welte
    European Journal of Medical Research, 15
  • [22] Vancomycin Versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Implications of the ZEPHyR Trial
    Alaniz, Cesar
    Pogue, Jason M.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (10) : 1432 - 1435
  • [23] Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis Effectiveness of linezolid in the elderly
    Takada, Hiroaki
    Hifumi, Toru
    Nishimoto, Naoki
    Kanemura, Takashi
    Yoshioka, Hayato
    Okada, Ichiro
    Kiriu, Nobuaki
    Inoue, Junichi
    Koido, Yuichi
    Kato, Hiroshi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (02): : 245 - 248
  • [24] Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
    Wunderink, RG
    Cammarata, SK
    Oliphant, TH
    Kollef, MH
    CLINICAL THERAPEUTICS, 2003, 25 (03) : 980 - 992
  • [25] NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) PNEUMONIA LINEZOLID OR VANCOMYCIN? - COMPARISON OF PHARMACOLOGY AND CLINICAL EFFICACY
    Pletz, Mathias W.
    Burkhardt, Olaf
    Welte, Tobias
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) : 507 - 513
  • [26] AN ECONOMIC MODEL TO COMPARE LINEZOLID AND VANCOMYCIN FOR THE TREATMENT OF CONFIRMED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA IN GERMANY
    Patel, D. A.
    Michel, A.
    Stephens, J. M.
    Weber, B.
    Gao, X.
    Charbonneau, C.
    VALUE IN HEALTH, 2013, 16 (07) : A354 - A354
  • [27] An economic model comparing linezolid and vancomycin for treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Patel, Dipen A.
    Shorr, Andrew F.
    Chastre, Jean
    Niederman, Michael
    Simor, Andrew
    Stephens, Jennifer M.
    Bhatt, Gaurang
    Charbonneau, Claudie
    Gao, Xin
    Nathwani, Dilip
    PHARMACOTHERAPY, 2013, 33 (10): : E214 - E214
  • [28] Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
    De Cock, E.
    Krueger, W. A.
    Sorensen, S.
    Baker, T.
    Hardewig, J.
    Duttagupta, S.
    Mueller, E.
    Piecyk, A.
    Reisinger, E.
    Resch, A.
    INFECTION, 2009, 37 (02) : 123 - 132
  • [29] Positive Phase IV results suggest higher rates of success for linezolid versus vancomycin for the treatment of MRSA nosocomial pneumonia
    不详
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (12) : 1330 - 1330
  • [30] An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
    Patel, Dipen A.
    Michel, Andre
    Stephens, Jennifer
    Weber, Bertram
    Petrik, Christian
    Charbonneau, Claudie
    INFECTION AND DRUG RESISTANCE, 2014, 7 : 273 - 280
12345